{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:24:50Z","timestamp":1768677890286,"version":"3.49.0"},"reference-count":69,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/ijo.2016.3518","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T11:00:21Z","timestamp":1463050821000},"page":"74-88","source":"Crossref","is-referenced-by-count":23,"title":["The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL-induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells"],"prefix":"10.3892","volume":"49","author":[{"given":"SEEMA-MARIA","family":"NATHWANI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LISA M.","family":"GREENE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEFANIA","family":"BUTINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIUSEPPE","family":"CAMPIANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. CLIVE","family":"WILLIAMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AFSHIN","family":"SAMALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EVA","family":"SZEGEZDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANIELA M.","family":"ZISTERER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"key20180107190303_b1-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"key20180107190303_b2-ijo-49-01-0074","first-page":"5","article-title":"Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia","volume":"4","author":"Banihashem","year":"2014","journal-title":"Iran J Ped Hematol Oncol"},{"key":"key20180107190303_b3-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2162-3619-3-16","article-title":"Childhood B-acute lymphoblastic leukemia: A genetic update","volume":"3","author":"Woo","year":"2014","journal-title":"Exp Hematol Oncol"},{"key":"key20180107190303_b4-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors","volume":"23","author":"Guicciardi","year":"2009","journal-title":"FASEB J"},{"key":"key20180107190303_b5-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.cdd.4401185","article-title":"Protein-based therapeutic approaches targeting death receptors","volume":"10","author":"French","year":"2003","journal-title":"Cell Death Differ"},{"key":"key20180107190303_b6-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2014.07.004","article-title":"Targeting death receptors for TRAIL by agents designed by Mother Nature","volume":"35","author":"Prasad","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"key20180107190303_b7-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.cr.7290311","article-title":"Expression of TRAIL and TRAIL receptors in normal and malignant tissues","volume":"15","author":"Daniels","year":"2005","journal-title":"Cell Res"},{"key":"key20180107190303_b8-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"key20180107190303_b9-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.molmed.2013.08.007","article-title":"TRAIL on trial: Preclinical advances in cancer therapy","volume":"19","author":"Stuckey","year":"2013","journal-title":"Trends Mol Med"},{"key":"key20180107190303_b10-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488709787047530","article-title":"TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges","volume":"4","author":"Bellail","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"key20180107190303_b11-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","article-title":"TRAIL receptor signalling and modulation: Are we on the right TRAIL?","volume":"35","author":"Mahalingam","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"key20180107190303_b12-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2007.15.7198","article-title":"Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2\/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L\/TRAIL)","volume":"26","author":"Ashkenazi","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107190303_b13-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/sj.onc.1206520","article-title":"TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB","volume":"22","author":"Ehrhardt","year":"2003","journal-title":"Oncogene"},{"key":"key20180107190303_b14-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood-2007-09-114314","article-title":"Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance","volume":"113","author":"Fakler","year":"2009","journal-title":"Blood"},{"key":"key20180107190303_b15-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-11-0434","article-title":"TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies","volume":"11","author":"Hellwig","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20180107190303_b16-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1200\/JCO.2008.21.7422","article-title":"Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: Results of a phase I and pharmacokinetic study","volume":"27","author":"Leong","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107190303_b17-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjc.6606035","article-title":"PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells","volume":"104","author":"Maginn","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107190303_b18-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/mol.105.021204","article-title":"Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines","volume":"70","author":"Mulligan","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20180107190303_b19-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3892\/ijo.2012.1688","article-title":"The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells","volume":"42","author":"Lysaght","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107190303_b20-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1158\/0008-5472.CAN-09-0131","article-title":"The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia","volume":"69","author":"McElligott","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107190303_b21-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.106.116640","article-title":"STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells","volume":"321","author":"Greene","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107190303_b22-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1042\/bst0290704","article-title":"Pyrrolo-1,5-benzoxazepines: A new class of apoptotic agents","volume":"29","author":"Zisterer","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"key20180107190303_b23-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00280-009-1200-9","article-title":"Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells","volume":"66","author":"Nathwani","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107190303_b24-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjc.6605670","article-title":"Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo","volume":"102","author":"Bright","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180107190303_b25-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1021\/jm049402y","article-title":"Pyrrolo[1,5]benzoxa(thia)zepines as a new class of potent apoptotic agents. Biological studies and identification of an intracellular location of their drug target","volume":"48","author":"Mc Gee","year":"2005","journal-title":"J Med Chem"},{"key":"key20180107190303_b26-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/protein\/gzh079","article-title":"Stabilization of TRAIL, an all-beta-sheet multimeric protein, using computational redesign","volume":"17","author":"van der Sloot","year":"2004","journal-title":"Protein Eng Des Sel"},{"key":"key20180107190303_b27-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1073\/pnas.0510187103","article-title":"Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor","volume":"103","author":"van der Sloot","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107190303_b28-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.107.039024","article-title":"BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines","volume":"73","author":"Greene","year":"2008","journal-title":"Mol Pharmacol"},{"key":"key20180107190303_b29-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3892\/or_00001011","article-title":"Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells","volume":"24","author":"Nathwani","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107190303_b30-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1074\/jbc.M109.090209","article-title":"Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors","volume":"285","author":"Sung","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107190303_b31-ijo-49-01-0074","first-page":"759","article-title":"Pretreatment with paclitaxel enhances apo-2 ligand\/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels","volume":"61","author":"Nimmanapalli","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107190303_b32-ijo-49-01-0074","first-page":"3193","article-title":"Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF","volume":"31","author":"Hunter","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107190303_b33-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"key20180107190303_b34-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/leu.2014.56","article-title":"Inhibitor of apoptosis (IAP) proteins in hematological malignancies: Molecular mechanisms and therapeutic opportunities","volume":"28","author":"Fulda","year":"2014","journal-title":"Leukemia"},{"key":"key20180107190303_b35-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1073\/pnas.0308050100","article-title":"Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107190303_b36-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2005.05679.x","article-title":"Phosphoinositide 3-kinase\/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias","volume":"130","author":"Tabellini","year":"2005","journal-title":"Br J Haematol"},{"key":"key20180107190303_b37-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: Getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"key":"key20180107190303_b38-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1517\/14728222.11.10.1299","article-title":"TRAIL in cancer therapy: Present and future challenges","volume":"11","author":"M\u00e9rino","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107190303_b39-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.exphem.2010.06.014","article-title":"Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis","volume":"38","author":"Akahane","year":"2010","journal-title":"Exp Hematol"},{"key":"key20180107190303_b40-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1021\/ac400994p","article-title":"Nanoarchitectured electrochemical cytosensors for selective detection of leukemia cells and quantitative evaluation of death receptor expression on cell surfaces","volume":"85","author":"Zheng","year":"2013","journal-title":"Anal Chem"},{"key":"key20180107190303_b41-ijo-49-01-0074","first-page":"335","article-title":"Molecular determinants of response to TRAIL in killing of normal and cancer cells","volume":"6","author":"Kim","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180107190303_b42-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1541-7786.MCR-08-0313","article-title":"TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5","volume":"6","author":"Zhang","year":"2008","journal-title":"Mol Cancer Res"},{"key":"key20180107190303_b43-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"14939","DOI":"10.1074\/jbc.M100399200","article-title":"Death domain mutagenesis of KILLER\/DR5 reveals residues critical for apoptotic signaling","volume":"276","author":"McDonald","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107190303_b44-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"43383","DOI":"10.1074\/jbc.M111.309377","article-title":"Importin \u03b21 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5\/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells","volume":"286","author":"Kojima","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107190303_b45-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"key20180107190303_b46-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-0031-1279762","article-title":"Combination of IFN\u03b3 and chemotherapeutic agents increase TRAIL sensitivity of neuroblastoma cell lines","volume":"21","author":"Tong","year":"2011","journal-title":"Eur J Pediatr Surg"},{"key":"key20180107190303_b47-ijo-49-01-0074","first-page":"e00017","article-title":"Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL","volume":"19","author":"Kim","year":"2012","journal-title":"Cell Biol Int Rep 2010"},{"key":"key20180107190303_b48-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1871520614666140829130047","article-title":"Bleomycin induced sensitivity to TRAIL\/Apo-2L-mediated apoptosis in human seminomatous testicular cancer cells is correlated with upregulation of death receptors","volume":"15","author":"Timur","year":"2015","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107190303_b49-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.intimp.2014.05.024","article-title":"Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP","volume":"21","author":"Venza","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"key20180107190303_b50-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)00003-9","article-title":"Apoptotic pathways: Paper wraps stone blunts scissors","volume":"102","author":"Green","year":"2000","journal-title":"Cell"},{"key":"key20180107190303_b51-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/cdd.2010.135","article-title":"BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane","volume":"18","author":"Schug","year":"2011","journal-title":"Cell Death Differ"},{"key":"key20180107190303_b52-ijo-49-01-0074","first-page":"176","article-title":"c-FLIP, a master anti-apoptotic regulator","volume":"34","author":"Safa","year":"2012","journal-title":"Exp Oncol"},{"key":"key20180107190303_b53-ijo-49-01-0074","first-page":"003","article-title":"Roles of c-FLIP in apoptosis, necroptosis, and autophagy","volume":"6","author":"Safa","year":"2013","journal-title":"J Carcinog Mutagen (Suppl)"},{"key":"key20180107190303_b54-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbrc.2014.05.106","article-title":"C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer","volume":"450","author":"Zang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107190303_b55-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/07357907.2011.605412","article-title":"Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP","volume":"29","author":"Ding","year":"2011","journal-title":"Cancer Invest"},{"key":"key20180107190303_b56-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1074\/jbc.M111.286526","article-title":"Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression","volume":"287","author":"Ding","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107190303_b57-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"362.e12","DOI":"10.1016\/j.ajog.2011.05.035","article-title":"Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells","volume":"205","author":"Li","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107190303_b58-ijo-49-01-0074","first-page":"12","article-title":"Mcl-1 as a therapeutic target in acute myelogenous leukemia (AML)","volume":"2","author":"Bose","year":"2013","journal-title":"Leuk Res Rep"},{"key":"key20180107190303_b59-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2013.09.015","article-title":"Reprogramming cell death: BCL2 family inhibition in hematological malignancies","volume":"155","author":"Scarf\u00f2","year":"2013","journal-title":"Immunol Lett"},{"key":"key20180107190303_b60-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.104.067561","article-title":"Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl] oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL","volume":"310","author":"McGee","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107190303_b61-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bcp.2013.12.017","article-title":"The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells","volume":"87","author":"Lennon","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"key20180107190303_b62-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3892\/ijo.2013.1989","article-title":"Inhibition of late-stage autophagy synergistically enhances pyrrolo-1,5-benzoxazepine-6-induced apoptotic cell death in human colon cancer cells","volume":"43","author":"Greene","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107190303_b63-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-8-39","article-title":"Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation","volume":"8","author":"Gill","year":"2009","journal-title":"Mol Cancer"},{"key":"key20180107190303_b64-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1535-7163.MCT-13-0153","article-title":"Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: Roles of XIAP and cIAPs","volume":"13","author":"Finlay","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"key20180107190303_b65-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yexcr.2010.10.005","article-title":"Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis","volume":"317","author":"Guicciardi","year":"2011","journal-title":"Exp Cell Res"},{"key":"key20180107190303_b66-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/cr.2009.80","article-title":"Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2\/Stat3","volume":"19","author":"Lanuti","year":"2009","journal-title":"Cell Res"},{"key":"key20180107190303_b67-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","article-title":"PI3K-Akt pathway: Its functions and alterations in human cancer","volume":"9","author":"Osaki","year":"2004","journal-title":"Apoptosis"},{"key":"key20180107190303_b68-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3324\/haematol.2013.096438","article-title":"Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K\/Akt pathway despite high PTEN protein levels","volume":"99","author":"Gomes","year":"2014","journal-title":"Haematologica"},{"key":"key20180107190303_b69-ijo-49-01-0074","doi-asserted-by":"crossref","first-page":"e80070","DOI":"10.1371\/journal.pone.0080070","article-title":"Differential effects of selective inhibitors targeting the PI3K\/AKT\/mTOR pathway in acute lymphoblastic leukemia","volume":"8","author":"Badura","year":"2013","journal-title":"PLoS One"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3518\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T15:27:48Z","timestamp":1567870068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,11]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/ijo.2016.3518"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3518","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}